Spero Therapeutics, Inc. ($SPRO)
Filing Information
| Accession Number | 0001193125-26-038441 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
251,586
Total Value
$101,174.60
P&L
+inf% (+$504,300.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Feb 2, 2026 | Grant/Award | 68,000 | $0.00 | $0.00 | 807,744 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 2, 2026 | Sale | 18,891 | $2.20 | $41,560.20 | 788,853 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 3, 2026 | Sale | 24,224 | $2.14 | $51,839.36 | 764,629 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 4, 2026 | Sale | 3,471 | $2.24 | $7,775.04 | 761,158 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 137,000 | $0.00 | $0.00 | 137,000 | Direct | โ | View Details |